Literature DB >> 17900298

Receptor-mediated transcytosis of botulinum neurotoxin A through intestinal cell monolayers.

Aurélie Couesnon1, Yannick Pereira, Michel R Popoff.   

Abstract

Botulism is mainly acquired by the oral route, and botulinum neurotoxin (BoNT) escapes the gastrointestinal tract by crossing the digestive epithelial barrier prior to gaining access to the nerve endings. Here, we show that biologically active BoNT/A crosses intestinal cell monolayers via a receptor-mediated transcytosis, including a transport inhibition at 4 degrees C and a passage at 37 degrees C in a saturable manner within 30-60 min. BoNT/A passage rate was about 10-fold more efficient through the intestinal crypt cell line m-IC(cl2), than through the carcinoma Caco-2 or T84 cells, and was not increased when BoNT/A was associated with the non-toxic proteins (botulinum complex). Like for neuronal cells, BoNT/A binding to intestinal cells was mediated by the half C-terminal domain as tested by fluorescence-activated cytometry and by transcytosis competition assay. A 'double receptor model' has been proposed in which BoNT/A interacts with gangliosides of GD(1b) and GT(1b) series as well as SV2 protein. Gangliosides of GD(1b) and GT(1b) series and recombinant intravesicular SV2-C domain partially impaired BoNT/A transcytosis, suggesting a putative role of gangliosides and SV2 or a related protein in BoNT/A transcytosis through Caco-2 and m-IC(cl2) cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900298     DOI: 10.1111/j.1462-5822.2007.01051.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  28 in total

1.  The botulinum toxin complex meets E-cadherin on the way to its destination.

Authors:  Yo Sugawara; Yukako Fujinaga
Journal:  Cell Adh Migr       Date:  2011-01-01       Impact factor: 3.405

2.  Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna-Magdalena Kruel; Stefan Mahrhold; Kay Perry; Luisa W Cheng; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2015-08-10       Impact factor: 3.033

3.  High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna Magdalena Kruel; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

Review 4.  Bacterial Signaling to the Nervous System through Toxins and Metabolites.

Authors:  Nicole J Yang; Isaac M Chiu
Journal:  J Mol Biol       Date:  2017-01-06       Impact factor: 5.469

5.  Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.

Authors:  David M White; Sabine Pellett; Mark A Jensen; William H Tepp; Eric A Johnson; Barry G W Arnason
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 6.  Membrane Transport across Polarized Epithelia.

Authors:  Maria Daniela Garcia-Castillo; Daniel J-F Chinnapen; Wayne I Lencer
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-09-01       Impact factor: 10.005

Review 7.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

Review 8.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 9.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

10.  Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.

Authors:  Yo Sugawara; Takuhiro Matsumura; Yuki Takegahara; Yingji Jin; Yoshikazu Tsukasaki; Masatoshi Takeichi; Yukako Fujinaga
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.